Agency Information Collection Activities: Submission for OMB Review; Comment Request, 54500-54501 [E6-15286]
Download as PDF
<![CDATA[
54500
Federal Register / Vol. 71, No. 179 / Friday, September 15, 2006 / Notices
grantee for the final budget and project
periods of Grant No. 90CVO172.
Big Brothers Big Sisters of Clinton and
Ionia Counties was responsible for
assisting children in Clinton and Ionia
Counties whose parents are incarcerated
to alleviate risk factors and to improve
their quality of life by providing them
with specially-trained adult mentors
who can provide supportive
relationships, guidance and
encouragement. As Big Brothers Big
Sisters of Michigan Capital Region is
proposing to continue services to the
same community with the same staff as
previously done by Big Brothers Big
Sisters of Clinton and Iona Counties, the
Family and Youth Services Bureau
(FYSB) is requesting that Big Brothers
Big Sisters of Michigan Capital Region
be granted a deviation to be funded as
the permanent successor grantee
without competition for the remaining
twelve months of the project period.
FOR FURTHER INFORMATION CONTACT:
Curtis Porter, Director, Youth
Development Division, Family and
Youth Services Bureau, Administration
for Children, Youth and Families,
Administration for Children and
Families, Portals Building, Suite 800,
1250 Maryland Avenue, SW.,
Washington, DC 20024. Telephone:
202–205–8102
Dated: September 8, 2006.
Joan E. Ohl,
Commissioner, Administration on Children,
Youth and Families.
[FR Doc. E6–15324 Filed 9–14–06; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Transmissible Spongiform
Encephalopathies Advisory
Committee; Amendment of Notice
AGENCY:
Food and Drug Administration,
HHS.
jlentini on PROD1PC65 with NOTICES
ACTION:
Notice.
The Food and Drug Administration
(FDA) is announcing an amendment to
the notice of the meeting of the
Transmissible Spongiform
Encephalopathies Advisory Committee.
This meeting was announced in the
Federal Register of August 3, 2006 (71
FR 44035). The amendment is being
made to reflect a change in the Date and
Time, Agenda, and Procedure portions
of the document. Specifically, the open
public hearing times in the Procedure
portion of the document were changed.
Because of a change in the agenda, the
VerDate Aug<31>2005
14:51 Sep 14, 2006
Jkt 208001
afternoon committee discussion topic
will be cancelled. There are no changes
other than those stated in this
announcement.
FOR FURTHER INFORMATION CONTACT:
William Freas or Rosanna L. Harvey,
Center for Biologics Evaluation and
Research (HFM–71), Food and Drug
Administration, 1401 Rockville Pike,
Rockville, MD 20852–1448, 301–827–
0314, or FDA Advisory Committee
Information Line, 1–800–741–8138
(301–443–0572 in the Washington, DC
area), code 3014512392.
SUPPLEMENTARY INFORMATION: In the
Federal Register of August 3, 2006, FDA
announced that a meeting of the
Transmissible Spongiform
Encephalopathies Advisory Committee
would be held September 18, 2006 from
8 a.m. to 4:30 p.m. and September 19,
2006 from 8 a.m. to 1 p.m. On page
44035, in the third column, the Date
and Time portion of the notice is
amended to read as follows:
Date and Time: The meeting will be
held on September 18, 2006, from 8:30
a.m. to 4 p.m. and September 19, 2006,
from 8 a.m. to 1 p.m.
On page 44036, in the first column,
the Agenda and Procedure portions of
the notice are amended to read as
follows:
Agenda: On September 18, 2006, the
committee will hear updates on the
following topics: United States and
worldwide bovine spongiform
encephalopathies (BSE); variant
Creutzfeldt-Jakob disease (vCJD)
epidemiology and transfusiontransmission; blood and plasma donor
deferral for transfusion in France since
1980 guidance; and critical factors
influencing prion decontamination
using sodium hydroxide. The committee
will then discuss experimental
clearance of transmissible spongiform
encephalopathy infectivity in plasmaderived Factor VIII products. In the
afternoon, the committee will hear
updates on the status of FDA’s initiative
on communication of the potential
exposure to vCJD risk from an
investigational product, plasma derived
FACTOR XI that was manufactured
from UK donor plasma, and a summary
of World Heath Organization
consultation on distribution of
infectivity in tissues of animals and
humans with transmissible spongiform
encephalopathies. On September 19,
2006, the committee will discuss
possible criteria for approval of donor
screening tests for vCJD.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
submissions may be made to the contact
person on or before September 6, 2006.
Oral presentations from the public will
be scheduled between approximately
11:30 a.m. and 12 noon and 3:30 p.m.
and 4 p.m. on September 18, 2006, and
between approximately 11:25 a.m. and
11:45 a.m. on September 19, 2006. Time
allotted for each presentation may be
limited. Those desiring to make formal
oral presentations should notify the
contact person and submit a brief
statement of the general nature of the
evidence or arguments they wish to
present, the names and addresses of
proposed participants, and an
indication of the approximate time
requested to make their presentation on
or before September 11, 2006.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. app.2) and 21 CFR part 14,
relating to the advisory committees.
Dated: September 6, 2006.
Randall W. Lutter,
Associate Commissioner for Policy and
Planning.
[FR Doc. E6–15283 Filed 9–14–06; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Health Resources
and Services Administration (HRSA)
publishes abstracts of information
collection requests under review by the
Office of Management and Budget
(OMB), in compliance with the
Paperwork Reduction Act of 1995 (44
U.S.C. Chapter 35). To request a copy of
the clearance requests submitted to
OMB for review, call the HRSA Reports
Clearance Office on (301) 443–1129.
The following request has been
submitted to the Office of Management
and Budget for review under the
Paperwork Reduction Act of 1995:
Proposed Project: Faculty Loan
Repayment Program (FLRP)
Application (OMB No. 0915–0150)—
Extension
Under the Health Resources and
Services Administration Faculty Loan
Repayment Program, health profession
graduates from a disadvantaged
background may enter into a contract
under which HRSA, with the
Department of Health and Human
Services, will make payments on
E:\FR\FM\15SEN1.SGM
15SEN1
Federal Register / Vol. 71, No. 179 / Friday, September 15, 2006 / Notices
eligible health professions educational
loans in exchange for a minimum of two
years of service as a full-time or parttime faculty member of an accredited
health professions college or university.
Applicants must complete an
application and provide all other
required documentation including
54501
information on all eligible health
professions educational loans.
The estimated response burden is as
follows:
Respondent
Number of
respondents
Responses
per response
Total
responses
Hours per
response
Total burden
hours
Applicants .............................................................................
160
1
160
1
160
Written comments and
recommendations concerning the
proposed information collection should
be sent within 30 days of this notice to:
John Kraemer, Human Resources and
Housing Branch, Office of Management
and Budget, New Executive Office
Building, Room 10235, Washington, DC
20503.
Dated: September 7, 2006.
Cheryl R. Dammons,
Director, Division of Policy Review and
Coordination.
[FR Doc. E6–15286 Filed 9–14–06; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
National Vaccine Injury Compensation
Program; List of Petitions Received
Health Resources and Services
Administration, HHS.
ACTION: Notice.
jlentini on PROD1PC65 with NOTICES
AGENCY:
SUMMARY: The Health Resources and
Services Administration (HRSA) is
publishing this notice of petitions
received under the National Vaccine
Injury Compensation Program (the
Program), as required by Section
2112(b)(2) of the Public Health Service
(PHS) Act, as amended. While the
Secretary of Health and Human Services
is named as the respondent in all
proceedings brought by the filing of
petitions for compensation under the
Program, the United States Court of
Federal Claims is charged by statute
with responsibility for considering and
acting upon the petitions.
FOR FURTHER INFORMATION CONTACT: For
information about requirements for
filing petitions, and the Program in
general, contact the Clerk, United States
Court of Federal Claims, 717 Madison
Place, NW., Washington, DC 20005,
(202) 357–6400. For information on
HRSA’s role in the Program, contact the
Director, National Vaccine Injury
Compensation Program, 5600 Fishers
Lane, Room 11C–26, Rockville, MD
20857; (301) 443–6593.
VerDate Aug<31>2005
14:51 Sep 14, 2006
Jkt 208001
The
Program provides a system of no-fault
compensation for certain individuals
who have been injured by specified
childhood vaccines. Subtitle 2 of Title
XXI of the PHS Act, 42 U.S.C. 300aa–
10 et seq., provides that those seeking
compensation are to file a petition with
the U.S. Court of Federal Claims and to
serve a copy of the petition on the
Secretary of Health and Human
Services, who is named as the
respondent in each proceeding. The
Secretary has delegated his
responsibility under the Program to
HRSA. The Court is directed by statute
to appoint special masters who take
evidence, conduct hearings as
appropriate, and make initial decisions
as to eligibility for, and amount of,
compensation.
A petition may be filed with respect
to injuries, disabilities, illnesses,
conditions, and deaths resulting from
vaccines described in the Vaccine Injury
Table (the Table) set forth at Section
2114 of the PHS Act or as set forth at
42 CFR 100.3, as applicable. This Table
lists for each covered childhood vaccine
the conditions which may lead to
compensation and, for each condition,
the time period for occurrence of the
first symptom or manifestation of onset
or of significant aggravation after
vaccine administration. Compensation
may also be awarded for conditions not
listed in the Table and for conditions
that are manifested outside the time
periods specified in the Table, but only
if the petitioner shows that the
condition was caused by one of the
listed vaccines.
Section 2112(b)(2) of the PHS Act, 42
U.S.C. 300aa–12(b)(2), requires that the
Secretary publish in the Federal
Register a notice of each petition filed.
Set forth below is a list of petitions
received by HRSA on April 1, 2006,
through June 30, 2006.
Section 2112(b)(2) also provides that
the special master ‘‘shall afford all
interested persons an opportunity to
submit relevant, written information’’
relating to the following:
1. The existence of evidence ‘‘that
there is not a preponderance of the
evidence that the illness, disability,
injury, condition, or death described in
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
the petition is due to factors unrelated
to the administration of the vaccine
described in the petition,’’ and
2. Any allegation in a petition that the
petitioner either:
(a) ‘‘Sustained, or had significantly
aggravated, any illness, disability,
injury, or condition not set forth in the
Table but which was caused by’’ one of
the vaccines referred to in the Table, or
(b) ‘‘Sustained, or had significantly
aggravated, any illness, disability,
injury, or condition set forth in the
Vaccine Injury Table the first symptom
or manifestation of the onset or
significant aggravation of which did not
occur within the time period set forth in
the Table but which was caused by a
vaccine’’ referred to in the Table.
This notice will also serve as the
special master’s invitation to all
interested persons to submit written
information relevant to the issues
described above in the case of the
petitions listed below. Any person
choosing to do so should file an original
and three (3) copies of the information
with the Clerk of the U.S. Court of
Federal Claims at the address listed
above (under the heading ‘‘For Further
Information Contact’’), with a copy to
HRSA addressed to Director, Division of
Vaccine Injury Compensation Program,
Healthcare Systems Bureau, 5600
Fishers Lane, Room 11C–26, Rockville,
MD 20857. The Court’s caption
(Petitioner’s Name v. Secretary of Health
and Human Services) and the docket
number assigned to the petition should
be used as the caption for the written
submission. Chapter 35 of title 44,
United States Code, related to
paperwork reduction, does not apply to
information required for purposes of
carrying out the Program.
List of Petitions
1. Bonnie and Paul Narducci on
behalf of Jonathan Paul Narducci,
Wallingford, Connecticut, Court of
Federal Claims Number 06–0266V.
2. Susan Walmsley, Bay Shore, New
York, Court of Federal Claims Number
06–0270V.
3. Kimberly and Norman Crawford on
behalf of Nicholas Timothy Crawford,
Porter, Texas, Court of Federal Claims
Number 06–0278V.
E:\FR\FM\15SEN1.SGM
15SEN1
]]>Agencies
[Federal Register Volume 71, Number 179 (Friday, September 15, 2006)]
[Notices]
[Pages 54500-54501]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-15286]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
Periodically, the Health Resources and Services Administration
(HRSA) publishes abstracts of information collection requests under
review by the Office of Management and Budget (OMB), in compliance with
the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35). To request
a copy of the clearance requests submitted to OMB for review, call the
HRSA Reports Clearance Office on (301) 443-1129.
The following request has been submitted to the Office of
Management and Budget for review under the Paperwork Reduction Act of
1995:
Proposed Project: Faculty Loan Repayment Program (FLRP) Application
(OMB No. 0915-0150)--Extension
Under the Health Resources and Services Administration Faculty Loan
Repayment Program, health profession graduates from a disadvantaged
background may enter into a contract under which HRSA, with the
Department of Health and Human Services, will make payments on
[[Page 54501]]
eligible health professions educational loans in exchange for a minimum
of two years of service as a full-time or part-time faculty member of
an accredited health professions college or university. Applicants must
complete an application and provide all other required documentation
including information on all eligible health professions educational
loans.
The estimated response burden is as follows:
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Responses per Total Hours per Total burden
Respondent respondents response responses response hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Applicants......................................................... 160 1 160 1 160
--------------------------------------------------------------------------------------------------------------------------------------------------------
Written comments and recommendations concerning the proposed
information collection should be sent within 30 days of this notice to:
John Kraemer, Human Resources and Housing Branch, Office of Management
and Budget, New Executive Office Building, Room 10235, Washington, DC
20503.
Dated: September 7, 2006.
Cheryl R. Dammons,
Director, Division of Policy Review and Coordination.
[FR Doc. E6-15286 Filed 9-14-06; 8:45 am]
BILLING CODE 4165-15-P
